ITeos Therapeutics Inc (NASDAQ: ITOS) is -1.04% lower on its value in year-to-date trading and has touched a low of $4.80 and a high of $18.70 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ITOS stock was last observed hovering at around $7.85 in the last trading session, with the day’s loss setting it -0.25%.
Currently trading at $7.60, the stock is 7.66% and 14.06% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.75 million and changing -3.18% at the moment leaves the stock -18.56% off its SMA200. ITOS registered -56.42% loss for a year compared to 6-month loss of -18.02%.
The stock witnessed a 37.43% gain in the last 1 month and extending the period to 3 months gives it a 4.25%, and is 18.01% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.96% over the week and 7.87% over the month.
ITeos Therapeutics Inc (ITOS) has around 173 employees, a market worth around $290.88M and $35.00M in sales. Profit margin for the company is -373.75%. Distance from 52-week low is 58.33% and -59.36% from its 52-week high. The company has generated returns on investments over the last 12 months (-23.07%).
The EPS is expected to grow by 12.53% this year
The shares outstanding are 38.27M, and float is at 33.10M with Short Float at 7.65%.
The top institutional shareholder in the company is BLACKROCK INC. with over 3.73 million shares valued at $55.37 million. The investor’s holdings represent 9.3983 of the ITOS Shares outstanding. As of 2024-06-30, the second largest holder is RA CAPITAL MANAGEMENT, L.P. with 3.52 million shares valued at $52.2 million to account for 8.8598 of the shares outstanding. The other top investors are ECOR1 CAPITAL, LLC which holds 3.25 million shares representing 8.1862 and valued at over $48.23 million, while BOXER CAPITAL, LLC holds 7.4231 of the shares totaling 2.95 million with a market value of $43.73 million.
ITeos Therapeutics Inc (ITOS) Insider Activity
The most recent transaction is an insider purchase by Gall Matthew, the company’s Chief Financial Officer. SEC filings show that Gall Matthew bought 5,000 shares of the company’s common stock on Nov 19 ’24 at a price of $7.73 per share for a total of $38635.0. Following the purchase, the insider now owns 65429.0 shares.
